Carret Asset Management, LLC Bristol Myers Squibb CO Transaction History

Carret Asset Management, LLC

$864 Million
Q1 2025

A detailed history of Carret Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Carret Asset Management, LLC holds 50,687 shares of BMY stock, worth $2.38 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

50,687

Previous 49,916 1.54%

Holding current value

$2.38 Million

Previous $2.82 Million 9.49%

% of portfolio

0.36%

Previous 0.32%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 22, 2025	BUY	$53.9 - $63.11 $41,556 - $48,657	771 Added 1.54%	50,687 $3.09 Million
Q4 2024 Feb 10, 2025	SELL	$51.92 - $59.94 $205,135 - $236,822	-3,951 Reduced 7.33%	49,916 $2.82 Million
Q3 2024 Oct 24, 2024	SELL	$39.66 - $51.75 $74,560 - $97,290	-1,880 Reduced 3.37%	53,867 $2.79 Million
Q2 2024 Aug 01, 2024	SELL	$40.25 - $52.99 $35,017 - $46,101	-870 Reduced 1.54%	55,747 $2.32 Million
Q1 2024 Apr 18, 2024	SELL	$47.98 - $54.4 $34,545 - $39,168	-720 Reduced 1.26%	56,617 $3.07 Million
Q4 2023 Feb 02, 2024	SELL	$48.48 - $57.85 $24,530 - $29,272	-506 Reduced 0.87%	57,337 $2.94 Million
Q3 2023 Oct 12, 2023	BUY	$57.89 - $64.73 $4,920 - $5,502	85 Added 0.15%	57,843 $3.36 Million
Q2 2023 Jul 25, 2023	SELL	$63.71 - $70.74 $85,498 - $94,933	-1,342 Reduced 2.27%	57,758 $3.69 Million
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $581,073 - $659,068	-8,843 Reduced 13.02%	59,100 $4.1 Million
Q4 2022 Jan 10, 2023	BUY	$68.48 - $81.09 $66,768 - $79,062	975 Added 1.46%	67,943 $4.89 Million
Q3 2022 Oct 11, 2022	SELL	$0.13 - $76.84 $78 - $46,104	-600 Reduced 0.89%	66,968 $4.76 Million
Q2 2022 Aug 04, 2022	SELL	$72.62 - $79.98 $11,909 - $13,116	-164 Reduced 0.24%	67,568 $5.2 Million
Q1 2022 Apr 13, 2022	BUY	$61.48 - $73.72 $23,669 - $28,382	385 Added 0.57%	67,732 $4.95 Million
Q4 2021 Jan 10, 2022	BUY	$53.63 - $62.52 $131,393 - $153,174	2,450 Added 3.78%	67,347 $4.2 Million
Q3 2021 Oct 27, 2021	SELL	$59.17 - $69.31 $381,646 - $447,049	-6,450 Reduced 9.04%	64,897 $3.84 Million
Q2 2021 Jul 14, 2021	BUY	$61.91 - $67.42 $43,213 - $47,059	698 Added 0.99%	71,347 $4.77 Million
Q1 2021 Jul 14, 2021	BUY	$59.34 - $66.74 $91,977 - $103,446	1,550 Added 2.24%	70,649 $4.46 Million
Q4 2020 Mar 16, 2021	BUY	$57.74 - $65.43 $66,401 - $75,244	1,150 Added 1.69%	69,099 $4.29 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $511,127 - $566,396	8,900 Added 15.07%	67,949 $4.1 Million
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $467,340 - $546,367	8,525 Added 16.87%	59,049 $3.47 Million
Q1 2020 May 18, 2020	BUY	$46.4 - $67.43 $533,321 - $775,040	11,494 Added 29.45%	50,524 $2.82 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $393,187 - $512,878	7,990 Added 25.74%	39,030 $2.51 Million
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $128,481 - $152,332	-3,004 Reduced 8.82%	31,040 $1.57 Million
Q2 2019 Aug 12, 2019	SELL	$44.62 - $49.34 $82,903 - $91,673	-1,858 Reduced 5.18%	34,044 $1.54 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $4,512 - $5,380	-100 Reduced 0.28%	35,902 $1.71 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $9,752 - $12,646	-200 Reduced 0.55%	36,002 $1.87 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $126,937 - $143,175	-2,300 Reduced 5.97%	36,202 $2.25 Million
Q2 2018 Aug 08, 2018	SELL	$50.53 - $62.98 $136,431 - $170,046	-2,700 Reduced 6.55%	38,502 $2.13 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $11,984 - $13,796	200 Added 0.49%	41,202 $2.61 Million
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $18,778 - $21,671	-340 Reduced 0.82%	41,002 $2.61 Million
Q2 2017 Aug 15, 2017	BUY	N/A	41,342	41,342 $2.3 Million

Others Institutions Holding BMY

# of Institutions

2,806

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.9B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carret Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carret Asset Management, LLC with notifications on news.

Account

Carret Asset Management, LLC Bristol Myers Squibb CO Transaction History